ARCHIVES

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

House approves $210 million for Dept. of Defense cancer research programs.

June 24, 2005

Clinical Center, NCI, NHLBI, Form Center For Interventional Oncology

April 24, 2009

NCI Advisory Group, Other Cancer Meetings

March 31, 1989

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

January 26, 2001

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

Hatfield, Kennedy Bill would Establish Panel for Clinical Research

February 16, 1996